W. J. Burman

3.3k total citations · 1 hit paper
24 papers, 2.5k citations indexed

About

W. J. Burman is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, W. J. Burman has authored 24 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 16 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in W. J. Burman's work include Tuberculosis Research and Epidemiology (15 papers), Mycobacterium research and diagnosis (8 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). W. J. Burman is often cited by papers focused on Tuberculosis Research and Epidemiology (15 papers), Mycobacterium research and diagnosis (8 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). W. J. Burman collaborates with scholars based in United States, Australia and United Kingdom. W. J. Burman's co-authors include Edward M. Gardner, Margaret Mclees, Carlos del Rı́o, John F. Steiner, Randall Reves, Marc Weiner, Joseph H. Bates, M. Donald Cave, Michael L. Wilson and Debra Benator and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and Journal of Allergy and Clinical Immunology.

In The Last Decade

W. J. Burman

24 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection

2011 1.5k citations Edward M. Gardner, Margaret Mclees et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. J. Burman United States	17	2.2k	1.8k	470	423	416	24	2.5k
Grace Macalino United States	25	932 0.4×	1.2k 0.6×	322 0.7×	229 0.5×	427 1.0×	65	2.2k
Ray Y. Chen United States	26	1.5k 0.7×	1.0k 0.5×	184 0.4×	572 1.4×	124 0.3×	44	1.9k
Eugene McCray United States	23	1.5k 0.7×	1.3k 0.7×	404 0.9×	188 0.4×	386 0.9×	42	2.1k
Susan E. Buskin United States	24	1.4k 0.6×	1.2k 0.6×	184 0.4×	397 0.9×	291 0.7×	74	2.0k
Julia C. Dombrowski United States	30	1.9k 0.9×	1.8k 1.0×	104 0.2×	406 1.0×	780 1.9×	146	2.9k
Pachamuthu Balakrishnan India	28	1.4k 0.6×	990 0.5×	179 0.4×	733 1.7×	195 0.5×	154	2.3k
Sharon Perry United States	19	1.5k 0.7×	726 0.4×	380 0.8×	460 1.1×	867 2.1×	31	2.7k
Helena Rabie South Africa	28	2.0k 0.9×	1.1k 0.6×	443 0.9×	602 1.4×	306 0.7×	176	2.9k
Stewart E. Reid Zambia	21	1.7k 0.8×	1.1k 0.6×	141 0.3×	531 1.3×	595 1.4×	54	2.4k
Robert Bolan United States	27	1.6k 0.7×	1.2k 0.7×	93 0.2×	342 0.8×	604 1.5×	102	2.3k

Countries citing papers authored by W. J. Burman

Since Specialization

Citations

This map shows the geographic impact of W. J. Burman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. J. Burman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. J. Burman more than expected).

Fields of papers citing papers by W. J. Burman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. J. Burman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. J. Burman. The network helps show where W. J. Burman may publish in the future.

Co-authorship network of co-authors of W. J. Burman

This figure shows the co-authorship network connecting the top 25 collaborators of W. J. Burman. A scholar is included among the top collaborators of W. J. Burman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. J. Burman. W. J. Burman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jenkins, T.C., Lilia Cervantes, Bryan Knepper, et al.. (2012). Targets for antibiotic and healthcare resource stewardship in inpatient community-acquired pneumonia: a comparison of management practices with National Guideline Recommendations. Infection. 41(1). 135–144. 22 indexed citations

Dooley, Kelly E., Erin Bliven-Sizemore, Marc Weiner, et al.. (2012). Safety and Pharmacokinetics of Escalating Daily Doses of the Antituberculosis Drug Rifapentine in Healthy Volunteers. Clinical Pharmacology & Therapeutics. 91(5). 881–888. 61 indexed citations

Bliven-Sizemore, Erin, John L. Johnson, Stefan Goldberg, et al.. (2012). Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment. The International Journal of Tuberculosis and Lung Disease. 16(4). 473–479. 5 indexed citations

Cohen, C, Homayoun Khanlou, W. J. Burman, et al.. (2012). A randomized pilot study of tenofovir/emtricitabine (TDF/FTC) + boosted atazanavir (ATV/r) vs. raltegravir (RAL BID) + ATV/r vs. RAL BID + ATV BID. Journal of the International AIDS Society. 15(S4). 1–1. 9 indexed citations

Gardner, Edward M., Margaret Mclees, John F. Steiner, Carlos del Rı́o, & W. J. Burman. (2011). The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection. Clinical Infectious Diseases. 52(6). 793–800. 1457 indexed citations breakdown →

Scano, Fabio, et al.. (2008). Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings.. PubMed. 12(12). 1370–5. 30 indexed citations

Weiner, Marc, Debra Benator, W. J. Burman, et al.. (2005). Association between Acquired Rifamycin Resistance and the Pharmacokinetics of Rifabutin and Isoniazid among Patients with HIV and Tuberculosis. Clinical Infectious Diseases. 40(10). 1481–1491. 170 indexed citations

Benator, Debra, Charles A. Peloquin, W. J. Burman, et al.. (2005). Evaluation of the Drug Interaction between Rifabutin and Efavirenz in Patients with HIV Infection and Tuberculosis. Clinical Infectious Diseases. 41(9). 1343–1349. 43 indexed citations

Bozeman, Lorna, W. J. Burman, Beverly Metchock, Lindsay Welch, & Marc Weiner. (2005). Fluoroquinolone Susceptibility among Mycobacterium tuberculosis Isolates from the United States and Canada. Clinical Infectious Diseases. 40(3). 386–391. 51 indexed citations

10.

Gardner, Edward M., et al.. (2005). Conventional and Molecular Epidemiology of Macrolide Resistance among New Mycobacterium avium Complex Isolates Recovered from HIV-Infected Patients. Clinical Infectious Diseases. 41(7). 1041–1044. 5 indexed citations

11.

Zhu, Min, W. J. Burman, Jeffrey R. Starke, et al.. (2004). Pharmacokinetics of ethambutol in children and adults with tuberculosis.. PubMed. 8(11). 1360–7. 62 indexed citations

12.

Burman, W. J.. (2003). Clinical and radiographic features of HIV-related tuberculosis1. PubMed. 18(4). 263–271. 41 indexed citations

13.

Burman, W. J., et al.. (2001). Inactivated Pronase as the Cause of False-Positive Results of Serum Cryptococcal Antigen Tests. Clinical Infectious Diseases. 32(5). 836–837. 8 indexed citations

14.

Burman, W. J., Randall Reves, Cornelis A. Rietmeijer, et al.. (1997). DNA Fingerprinting With Two Probes Decreases Clustering of Mycobacterium Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 155(3). 1140–1146. 79 indexed citations

15.

Burman, W. J., Randall Reves, Michael L. Wilson, et al.. (1997). The Incidence of False-Positive Cultures for Mycobacterium Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 155(1). 321–326. 77 indexed citations

16.

Burman, W. J., et al.. (1997). The diagnostic yield of acid-fast-bacillus smear-positive sputum specimens. Journal of Clinical Microbiology. 35(4). 1030–1031. 19 indexed citations

17.

Coeshott, Claire, et al.. (1996). 656 Sulfamethoxazole-specific antibodies in patients with AIDS: a prospective study. Journal of Allergy and Clinical Immunology. 97(1). 346–346. 4 indexed citations

18.

Yang, Zhenhua, Fernando Cháves, Peter F. Barnes, et al.. (1996). Evaluation of method for secondary DNA typing of Mycobacterium tuberculosis with pTBN12 in epidemiologic study of tuberculosis. Journal of Clinical Microbiology. 34(12). 3044–3048. 38 indexed citations

19.

Cháves, Fernando, Zhenhua Yang, Hiba El Hajj, et al.. (1996). Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis. Journal of Clinical Microbiology. 34(5). 1118–1123. 113 indexed citations

20.

Burman, W. J., David L. Cohn, Randall Reves, & Michael L. Wilson. (1995). Multifocal Cellulitis and Monoarticular Arthritis as Manifestations of Helicobacter cinaedi Bacteremia. Clinical Infectious Diseases. 20(3). 564–570. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact